What people are saying - Write a review
We haven't found any reviews in the usual places.
Aspects of NonSpecific Immunotherapy With BCG in Superficial Bladder
History of BCG and Its Substrains
Fundamentals of Active Specific Immunotherapy of Cancer Using
13 other sections not shown
Other editions - View all
adjuvant Adriamycin antigens antitumor activity Bacillus Calmette-Guerin BCG immunotherapy BCG in Superficial BCG therapy BCG treatment BCG-RIVM BCG-Tice biopsies bladder carcinoma Brosman Catalona WJ chemotherapy clinical complete response Crispen cystectomy cystitis cystoscopy cytology Department of Urology developed disease dose Doxorubicin drugs Editors Vol EORTC grade granulomatous guinea pig Haaff hematuria histologic immune response induction intra intravesical Bacillus Calmette-Guerin intravesical BCG intravesical instillation intravesical therapy Isoniazid lamina propria Lamm DL lesions lymph nodes macrophages Meijden Mitomycin-C months muscle invasion Mycobacterium bovis natural killer cell Oncology papillary tumors patients treated patients with superficial Pinsky CM progression prophylaxis prostatic protocol Ratliff TL reaction recurrence rate reported side effects Soloway strain superficial bladder cancer superficial bladder tumors systemic TABLE Thiotepa tion toxicity transitional cell carcinoma treated patients treatment of superficial TTPA tumor cells tumor recurrence urinary Urol Urology urothelial urothelium vaccine vesical weeks Whitmore Jr WF